Gritstone Bio Inc (GRTS)
0.7466
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
0.73
-0.02
(-2.22%)
After-Hours: 20:00
Gritstone Bio Cash from Operations (TTM): -115.12M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -115.12M |
December 31, 2023 | -121.65M |
September 30, 2023 | -132.51M |
June 30, 2023 | -127.21M |
March 31, 2023 | -122.58M |
December 31, 2022 | -115.95M |
September 30, 2022 | -109.35M |
June 30, 2022 | -98.44M |
March 31, 2022 | -94.78M |
December 31, 2021 | -50.68M |
September 30, 2021 | -52.12M |
Date | Value |
---|---|
June 30, 2021 | -57.42M |
March 31, 2021 | -55.47M |
December 31, 2020 | -89.10M |
September 30, 2020 | -86.34M |
June 30, 2020 | -91.18M |
March 31, 2020 | -88.86M |
December 31, 2019 | -85.01M |
September 30, 2019 | -75.56M |
June 30, 2019 | -48.63M |
March 31, 2019 | -42.23M |
December 31, 2018 | -38.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-132.51M
Minimum
Sep 2023
-48.63M
Maximum
Jun 2019
-90.90M
Average
-90.14M
Median
Cash from Operations (TTM) Benchmarks
Precision BioSciences Inc | -71.63M |
Humacyte Inc | -82.01M |
Verastem Inc | -94.48M |
BioVie Inc | -41.11M |
Adial Pharmaceuticals Inc | -6.807M |